Evidence map›Paper›PMID 25191835›Full record

ArticlePloS one2014

DNA methylation is dispensable for suppression of the agouti viable yellow controlling element in murine embryonic stem cells.

Athanasia Stathopoulou, Giulia Lucchiari, Steen K T Ooi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Athanasia StathopoulouDepartment of Cancer Biology, University College London Cancer Institute, London, United Kingdom.
Giulia LucchiariDepartment of Cancer Biology, University College London Cancer Institute, London, United Kingdom.
Steen K T OoiDepartment of Cancer Biology, University College London Cancer Institute, London, United Kingdom.
London Cancer · GBUniversity College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H022546/1
6 · The paper itself

Abstract

The agouti viable (Avy) locus is considered a model to understand how retroelements function as controlling elements in mammals. Epigenetic factors, principally CpG methylation, are widely held to play a dominant regulatory role in controlling the locus' activity. The purpose of this study was to examine its behavior in ES cells and determine if this locus could be exploited for use in screen-based investigations. We have derived multiple Avy ES cell lines from the C57BL/6 strain and generated a cell line carrying a GFP-reporter gene (Avy/AGFP). Use of the DNA demethylating drug 5-azacitidine on various ES cell lines does not induce either agouti or GFP expression. Methylation analysis reveals that although most lines display normal methylation at IAP elements in general, the Avy IAP element is essentially unmethylated. In addition, we find that different repeat compartments are epigenetically unstable in a number of derived cell lines.

Indexed as

DNA MethylationRegulatory Sequences, Nucleic AcidAgouti Signaling ProteinAnimalsCell LineCells, CulturedDown-RegulationEmbryo, MammalianEmbryonic Stem CellsFemaleGene Expression Regulation, DevelopmentalGenes, Intracisternal A-ParticleMaleMiceMice, Inbred C57BLAgouti Signaling Protein

Identifiers

PMID25191835
PMCPMC4156423
OpenAlexW2012995256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.